Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
It is possible that, in addition to factors such as reduced alcohol consumption, weight loss-related improvements in body image, or relief associated with better glycaemic control in diabetes, there may also be direct neurobiological mechanisms involved for example, through changes in the functioning of the brains reward system. Read the report in The Lancet Psychiatry Read more about type 2 diabetes I would like to make a regular donation of
The starter pen delivers 0.25 mg or 0.5 mg doses and contains 2 mg total in 1.5 mL (concentration: approximately 1.34 mg/mL)
"FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide from the 503B Bulks List." April 30, 2026
Compounded means the same active molecule, but not FDA-approved for safety, efficacy, or quality, and 503A compounding sits in a legally narrow lane post-shortage
Source: Jastreboff et al., NEJM 2023 TRIUMPH-4 Phase 3 (68 weeks, 445 participants) Phase 2 Type 2 Diabetes Trial (36 weeks, 281 participants) In the type 2 diabetes population, weight loss was lower than in the obesity trial which is consistent with the pattern seen across all GLP-1 drugs
US$ 22.55
US$ 25.37
US$ 20.59
US$ 24.87
US$ 29.78
